The structure of collagen fibers may play a key role in the spread of breast cancer, with implications for clinical prognosis and treatment.
Jingmei Li is developing a risk scoring system for breast cancer that could help clinicians formulate better screening programs to catch the disease in its early stages.
By taking advantage of the body’s
natural diversity, antibody drugs can be made less toxic by having a more localized
for genetic quirk can provide a wealth of
information on patient disease status and prognosis
The paradoxical roles of well-known cancer genes are mediated by oxygen levels in breast cancer
Therapeutic target takes aim at a virulent strain of cancer
process that combines multiple components through quick, consecutive reactions is
promising for drug manufacture
A biocompatible polymer selectively targets and lights up cancer tumors for a noninvasive imaging system
A nontoxic hydrogel developed by the A*STAR Institute of Bioengineering and Nanotechnology and IBM Research offers a new way forward for breast cancer therapeutics